News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
833,945 Results
Type
Article (85782)
Company Profile (649)
Press Release (747514)
Section
Business (232067)
Career Advice (4121)
Deals (39688)
Drug Delivery (124)
Drug Development (90695)
Employer Resources (195)
FDA (17950)
Job Trends (17295)
News (395244)
Policy (39616)
Tag
Academia (2977)
Alliances (56563)
Alzheimer's disease (1399)
Antibody-drug conjugate (ADC) (111)
Approvals (17929)
Artificial intelligence (182)
Bankruptcy (399)
Best Places to Work (12511)
Biotechnology (447)
Breast cancer (185)
Cancer (1535)
Career advice (3523)
CAR-T (130)
Cell therapy (374)
Clinical research (72143)
Collaboration (621)
Compensation (311)
COVID-19 (2807)
C-suite (149)
Data (1384)
Diabetes (151)
Diagnostics (6700)
Earnings (94462)
Employer resources (166)
Events (127250)
Executive appointments (482)
FDA (18652)
Funding (522)
Gene therapy (257)
GLP-1 (684)
Government (5051)
Healthcare (20708)
Infectious disease (2898)
Inflammatory bowel disease (132)
Interviews (810)
IPO (17656)
Job creations (5182)
Job search strategy (2859)
Layoffs (510)
Legal (10038)
Lung cancer (234)
Manufacturing (223)
Medical device (14271)
Medtech (14276)
Mergers & acquisitions (22165)
Metabolic disorders (486)
Neuroscience (1781)
NextGen: Class of 2025 (7660)
Non-profit (5053)
Northern California (1837)
Obesity (266)
Opinion (259)
Patents (141)
People (64497)
Pharmaceutical (131)
Phase I (22277)
Phase II (31371)
Phase III (23576)
Pipeline (635)
Postmarket research (3541)
Preclinical (9996)
Radiopharmaceuticals (246)
Rare diseases (301)
Real estate (7375)
Regulatory (26134)
Research institute (2640)
Resumes & cover letters (649)
Southern California (1564)
Startups (4277)
United States (16199)
Vaccines (668)
Weight loss (205)
Date
Today (125)
Last 7 days (530)
Last 30 days (2171)
Last 365 days (32205)
2025 (3595)
2024 (34028)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1262)
Arizona (226)
Asia (49543)
Australia (8748)
California (4191)
Canada (1363)
China (373)
Colorado (135)
Connecticut (180)
Europe (113355)
Florida (508)
Georgia (112)
Illinois (397)
Indiana (227)
Maryland (710)
Massachusetts (3367)
Michigan (169)
Minnesota (277)
New Jersey (1194)
New York (1170)
North Carolina (891)
Northern California (1837)
Ohio (141)
Pennsylvania (912)
South America (1646)
Southern California (1564)
Texas (551)
Washington State (445)
833,945 Results for "aditum bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders
November 7, 2024
·
3 min read
Biotech Bay
Aditum Bio Announces Formation of Celexor Bio, Focused on Cell Depletion of Pathologic Cells in Autoimmune and Inflammatory Disorders
Aditum Bio, the biotech investment firm cofounded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research (NIBR) Dr. Mark Fishman, today announced the formation of Celexor Bio, a portfolio company created for the development of novel therapies for inflammatory disorders.
September 21, 2023
·
3 min read
Biotech Beach
Aditum Bio Announces Formation of Vitalli Bio, Focused on Immunological Disorders
Aditum Bio, the biotech investment firm cofounded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research Dr. Mark Fishman, announced the formation of Vitalli Bio, a portfolio company created for the development of novel therapies for immunological disorders.
April 27, 2023
·
3 min read
Layoffs
Passage Bio Cutting 55% of Staff to Help Extend Cash Runway
Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues evaluating a treatment for frontotemporal dementia with granulin mutations.
January 13, 2025
·
1 min read
·
Angela Gabriel
Business
Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function
Inmagene Biopharmaceuticals today announced its partnership with Aditum Bio to create Celexor Bio (Celexor), a new biotech company focused on cell depletion of pathologic cells in autoimmune and inflammatory disorders.
September 21, 2023
·
3 min read
Press Releases
Cathay Biotech to showcase thermoplastic bio-based composite materials (bio-PPA CFRT) at 2025 JEC World
February 11, 2025
·
2 min read
Press Releases
Vivacelle Bio to Participate in BIO Partnering @ JPM Week 2025
January 10, 2025
·
2 min read
Layoffs
Bluebird Bio to Lay Off 25% of Workforce
About a month after reporting it’s had a tough time starting enough patients on its treatments, bluebird bio announced it will lay off about 25% of its employees, over half of whom work in R&D.
September 24, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Bio-Path Holdings Expands Global Patent Portfolio
February 14, 2025
·
4 min read
Press Releases
Bio-Path Holdings Provides Key Clinical Updates
February 14, 2025
·
6 min read
1 of 83,395
Next